Elaine A Moore
Promise of Low Dose Naltrexone Therapy
Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Buch
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects…
Mehr
Beschreibung
Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS). Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers.
CHF 40.90
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
Weitere Autoren: Wilkinson, Samantha
- ISBN: 978-0-7864-3715-3
- EAN: 9780786437153
- Produktnummer: 3807638
- Verlag: McFarland and Company, Inc.
- Sprache: Englisch
- Erscheinungsjahr: 2008
- Seitenangabe: 224 S.
- Masse: H22.9 cm x B15.2 cm x D1.2 cm 332 g
- Abbildungen: Paperback
- Gewicht: 332
Über den Autor
Elaine A. Moore has worked in hospital laboratories for more than 30 years, primarily in immunohematology and toxicology. She is a freelance medical writer and laboratory consultant.
23 weitere Werke von Elaine A Moore:
Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Ebook (PDF Format)
CHF 71.60
Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Ebook (PDF Format)
CHF 76.10
Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Ebook (PDF Format)
CHF 48.35
Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders
Ebook (EPUB Format)
CHF 76.10
Bewertungen
0 von 0 Bewertungen
Anmelden
Keine Bewertungen gefunden. Seien Sie der Erste und teilen Sie Ihre Erkenntnisse mit anderen.